CIK 0001490978 · Large accelerated filer
Schrodinger, Inc.
Sign in to watch- Ticker
- SDGR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954284541
- Phone
- 503-299-1150
- Business address
- 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,781,663
- in 3 filings, $2.8M under 10b5-1 plans
Net −$2,781,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-03 | Porges Geoffrey Craig EVP & CFO | Sale | −5,491 | $21.76 | $119K | 27,544 |
| 2025-03-03 | Porges Geoffrey Craig EVP & CFO | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-03-03 | Akinsanya Karen President of R&D, Therapeutics | Grant or award | +15,625 | 15,625 | ||
| 2025-03-03 | Akinsanya Karen President of R&D, Therapeutics | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2025-03-03 | Farid Ramy President & CEO | Grant or award | +37,500 | 221,932 | ||
| 2025-03-03 | Farid Ramy President & CEO | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-03-03 | Farid Ramy President & CEO | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2025-03-03 | Dugan Margaret Chief Medical Officer | Grant or award | +12,500 | 25,969 | ||
| 2025-03-03 | Dugan Margaret Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-03-03 | Herman Jenny SVP & Controller | Grant or award | +9,800 | 28,015 | ||
| 2025-03-03 | Herman Jenny SVP & Controller | Grant or award · Stock Option (right to buy) | +8,400 | 8,400 | ||
| 2025-03-03 | Lorton Kenneth Patrick EVP, CTO & COO, Software | Grant or award | +12,500 | 53,576 | ||
| 2025-03-03 | Lorton Kenneth Patrick EVP, CTO & COO, Software | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-03-03 | Tran Yvonne EVP, CLO & CPO | Grant or award | +12,500 | 23,635 | ||
| 2025-03-03 | Tran Yvonne EVP, CLO & CPO | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-03-03 | Abel Robert Lorne See Remarks | Grant or award | +12,500 | 20,615 | ||
| 2025-03-03 | Abel Robert Lorne See Remarks | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-02-18 | Tran Yvonne EVP, CLO & CPO | Option exercise 10b5-1 | +3,902 | $4.34 | $17K | 15,037 |
| 2025-02-18 | Tran Yvonne EVP, CLO & CPO | Sale 10b5-1 | −3,902 | $28.00 | $109K | 11,135 |
| 2025-02-18 | Tran Yvonne EVP, CLO & CPO | Option exercise · Stock Option (right to buy) 10b5-1 | −3,902 | 0 |
Page 7 of 11 · 214 trades